Skip to main content

Peer Review reports

From: Capecitabine plus bevacizumab versus capecitabine in maintenance treatment for untreated characterised KRAS exon 2 wild-type metastatic colorectal cancer: a retrospective analysis in Chinese postmenopausal women

Original Submission
4 Oct 2018 Submitted Original manuscript
29 Oct 2018 Reviewed Reviewer Report - Ridhi Gupta
16 Nov 2018 Reviewed Reviewer Report - Kuan-Chih Chen
24 Nov 2018 Author responded Author comments - Jinsong Su
Resubmission - Version 2
24 Nov 2018 Submitted Manuscript version 2
26 Nov 2018 Author responded Author comments - Jinsong Su
Resubmission - Version 3
26 Nov 2018 Submitted Manuscript version 3
28 Nov 2018 Author responded Author comments - Jinsong Su
Resubmission - Version 4
28 Nov 2018 Submitted Manuscript version 4
Publishing
3 Dec 2018 Editorially accepted
25 Jan 2019 Article published 10.1186/s12876-018-0916-6

You can find further information about peer review here.

Back to article page